Telisotuzumab(ABT-700) is a humanized recombinant antibody targeting the therapeutic hepatocyte growth factor receptor (MET) with high affinity for c-Met.Telisotuzumab has inhibitory effects on c-Met signaling and antitumor activity.
CAS Number:
[1781223-80-0]
Target:
ABT-700 , Mab-224G11
* VAT and and shipping costs not included. Errors and price changes excepted